-
The cellular state space of AML unveils novel NPM1 subtypes with distinct clinical outcomes and immune evasion properties
Study
EGAS50000001084
-
Sequence data to study genomic CNVs that drive apoptotic resistance and relapses on immune checkpoint inhibitors
Study
EGAS50000001055
-
SF3B1 splicing signature
Study
EGAS50000001473
-
TransNEO neoadjuvant breast cancer study
Study
EGAS00001004582
-
MATISSE WES and bulk RNA-sequencing data
Study
EGAS50000001003
-
A prospective multicenter study of plasma ctDNA versus archival tumor tissue to guide FGFR-targeted therapy in metastatic urothelial cancer - Targeted
Study
EGAS50000001450
-
Transcriptomic Data from Patients with Advanced Rare Cancers Treated with Pembrolizumab
Study
EGAS50000001509
-
Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia
Study
EGAS50000000106
-
Comprehensive genetic landscape, immune checkpoint profiling, and establishment of patient-derived xenograft (PDX) of metachronous brain tumors from constitutive mismatch repair deficiency with a biallelic variant on MSH6
Study
EGAS50000000351
-
PTEN homozygous deletion is a negative prognostic factor in Tumor Treating Fields-treated glioblastoma, IDH wildtype patients
Study
EGAS50000001469